U.S. law classifying drugs and shaping federal drug policy
The U.S. Department of Justice and Walmart have reached a settlement over claims that Walmart pharmacies violated the Controlled Substances Act by failing to report red flags tied to opioid prescriptions. Walmart has not admitted liability. The settlement resolves claims from 2013 onward, with earlier related actions already settled in 2022. Walmart shares edged higher after the announcement.
The Justice Department has reached a settlement with CVS over a 2024 lawsuit that accused the company of dispensing large quantities of opioids and other controlled substances to fuel profits, sidelining public health. The agreement requires additional safeguards to ensure prescriptions are medically appropriate, with no admission of wrongdoing by CVS.